108 related articles for article (PubMed ID: 30916931)
1. Nitrooxidoreductase Rv2466c-Dependent Fluorescent Probe for Mycobacterium tuberculosis Diagnosis and Drug Susceptibility Testing.
Mu R; Kong C; Yu W; Wang H; Ma Y; Li X; Wu J; Somersan-Karakaya S; Li H; Sun Z; Liu G
ACS Infect Dis; 2019 Jun; 5(6):949-961. PubMed ID: 30916931
[TBL] [Abstract][Full Text] [Related]
2. Optimization of nitrofuranyl calanolides for the fluorescent detection of Mycobacterium tuberculosis.
Geng P; Hong X; Li X; Ni D; Liu G
Eur J Med Chem; 2022 Dec; 244():114835. PubMed ID: 36270089
[TBL] [Abstract][Full Text] [Related]
3. Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis.
Albesa-Jové D; Chiarelli LR; Makarov V; Pasca MR; Urresti S; Mori G; Salina E; Vocat A; Comino N; Mohorko E; Ryabova S; Pfieiffer B; Lopes Ribeiro AL; Rodrigo-Unzueta A; Tersa M; Zanoni G; Buroni S; Altmann KH; Hartkoorn RC; Glockshuber R; Cole ST; Riccardi G; Guerin ME
ACS Chem Biol; 2014 Jul; 9(7):1567-75. PubMed ID: 24877756
[TBL] [Abstract][Full Text] [Related]
4. Detecting
Li X; Geng P; Hong X; Sun Z; Liu G
Chem Commun (Camb); 2021 Dec; 57(97):13174-13177. PubMed ID: 34812827
[TBL] [Abstract][Full Text] [Related]
5. The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of
Rosado LA; Wahni K; Degiacomi G; Pedre B; Young D; de la Rubia AG; Boldrin F; Martens E; Marcos-Pascual L; Sancho-Vaello E; Albesa-Jové D; Provvedi R; Martin C; Makarov V; Versées W; Verniest G; Guerin ME; Mateos LM; Manganelli R; Messens J
J Biol Chem; 2017 Aug; 292(32):13097-13110. PubMed ID: 28620052
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosis.
Negri A; Javidnia P; Mu R; Zhang X; Vendome J; Gold B; Roberts J; Barman D; Ioerger T; Sacchettini JC; Jiang X; Burns-Huang K; Warrier T; Ling Y; Warren JD; Oren DA; Beuming T; Wang H; Wu J; Li H; Rhee KY; Nathan CF; Liu G; Somersan-Karakaya S
ACS Infect Dis; 2018 May; 4(5):771-787. PubMed ID: 29465985
[TBL] [Abstract][Full Text] [Related]
7. The Redox State Regulates the Conformation of Rv2466c to Activate the Antitubercular Prodrug TP053.
Albesa-Jové D; Comino N; Tersa M; Mohorko E; Urresti S; Dainese E; Chiarelli LR; Pasca MR; Manganelli R; Makarov V; Riccardi G; Svergun DI; Glockshuber R; Guerin ME
J Biol Chem; 2015 Dec; 290(52):31077-89. PubMed ID: 26546681
[TBL] [Abstract][Full Text] [Related]
8. Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics.
Buchmeier NA; Newton GL; Koledin T; Fahey RC
Mol Microbiol; 2003 Mar; 47(6):1723-32. PubMed ID: 12622824
[TBL] [Abstract][Full Text] [Related]
9. Rapid drug-susceptibility testing of Mycobacterium tuberculosis clinical isolates to first-line antitubercular drugs by nitrate reductase assay: A comparison with proportion method.
Kohli A; Bashir G; Fatima A; Jan A; Wani NU; Ahmad J
Int J Mycobacteriol; 2016 Dec; 5(4):469-474. PubMed ID: 27931689
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of ethambutol-resistant
Chauhan DS; Sharma R; Parashar D; Das R; Sharma P; Singh AV; Singh PK; Katoch K; Katoch VM
Indian J Med Microbiol; 2018; 36(2):211-216. PubMed ID: 30084413
[TBL] [Abstract][Full Text] [Related]
11. A high throughput methodology for susceptibility testing of Mycobacterium tuberculosis isolates.
Rampersad T; Makume M; Sobia P; Willem Sturm A
J Microbiol Methods; 2018 Mar; 146():64-67. PubMed ID: 29410256
[TBL] [Abstract][Full Text] [Related]
12. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
13. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran.
Nasiri MJ; Rezaei F; Zamani S; Darban-Sarokhalil D; Fooladi AA; Shojaei H; Feizabadi MM
Asian Pac J Trop Med; 2014 Mar; 7(3):193-6. PubMed ID: 24507638
[TBL] [Abstract][Full Text] [Related]
15. Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium tuberculosis.
Burke RM; Coronel J; Moore D
J Med Microbiol; 2017 Jul; 66(7):1023-1026. PubMed ID: 28759352
[TBL] [Abstract][Full Text] [Related]
16. [Clinical application of testing methods on acid-fast bacteria].
Ichiyama S; Suzuki K
Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982
[TBL] [Abstract][Full Text] [Related]
17. Microbial sensor for drug susceptibility testing of Mycobacterium tuberculosis.
Zhang ZT; Wang DB; Li CY; Deng JY; Zhang JB; Bi LJ; Zhang XE
J Appl Microbiol; 2018 Jan; 124(1):286-293. PubMed ID: 29055163
[TBL] [Abstract][Full Text] [Related]
18. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance mechanisms and drug susceptibility testing for tuberculosis.
Miotto P; Zhang Y; Cirillo DM; Yam WC
Respirology; 2018 Dec; 23(12):1098-1113. PubMed ID: 30189463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
